drugset / Trial / NCT02953327

Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau

NCT02953327

RandomizedParallel-groupSingle-blindBasic science

Summary

The propose is to test innate immune training in a pilot study of 40 adults \>50 years of age people in Guinea-Bissau. The hypothesis is that BCG vaccination will be associated with increased innate immune training measured as increased cytokine release after in vitro Peripheral Blood Mononuclear Cells (PBMC) stimulation with e.g. Mycobacterium Tuberculosis, Staphylococcus Aureus, Candida Albicans and Streptococcus Pneumoniae.

Timeline

Start
2017-02-01
Primary completion
2017-06-15
Completion
2020-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacille Calmette-Guerin Vaccine Other

Indications

No indication recorded.